In the phase II trial published in the New England Journal of Medicine (2023), retatrutide demonstrated substantial weight loss efficacy, with participants achieving up to approximately 24% mean body weight reduction at the highest doses over 48 weeks
E., Locatelli, V., & Cocchi, D
In these studies, hydrolysed, rather than intact, whey protein was selected because it more closely resembles partially digested protein
The long half-life of semaglutide (approximately one week) means that after seven days, about half of the medication is still in your system
Rosen said the findings raise pressing questions: Does bone loss continue as long as weight loss does